|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
4.320 -0.120 (-2.703%) | 2023/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | 2019/09 RMB(K¥) | |
| Turnover | 12,956,000 | 12.655% | 11,500,569 | 9,357,715 | 7,162,031 | 4,116,846 |
| Cost of Sales | (10,087,332) | 9.646% | (9,199,913) | (7,486,940) | (5,301,715) | (3,085,186) |
| Gross Profit | 2,868,668 | 24.689% | 2,300,656 | 1,870,775 | 1,860,316 | 1,031,660 |
| 2023/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | 2019/09 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (8,191) | -- | 385 | (24,385) | (38,901) | (23,762) | |
| Profit / (Loss) before Taxation | 481,271 | 176.632% | 173,975 | (229,862) | 324,441 | 5,628 | |
| Taxation | (36,128) | 245.194% | (10,466) | (1,706) | (45,887) | (13,257) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 748 | -- | (1,315) | (203) | 4,877 | 6,527 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 445,891 | 174.912% | 162,194 | (231,771) | 283,431 | (1,102) | |
| 2023/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | 2019/09 RMB(K¥) | |
| Net Finance Costs / (Income) | (201,856) | 41.019% | (143,141) | (85,721) | (61,001) | 2,790 |
| Depreciation & Amortisation | 25,225 | -29.730% | 35,897 | 23,059 | 17,534 | 18,886 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| EPS (cts) | 3.300 | 175.000% | 1.200 | -1.720 | 2.170 | -0.010 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.189 | -- | -- | 1.043 | 1.075 | 0.418 |
| Remarks: | Real time quote last updated: 08/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 883,477 |
| %Change | 64.935% |
| EPS / (LPS) | RMB 0.063 |
| NBV Per Share (¥) | RMB 0.904 |